BioPharma Resources

Drug Trial Radar · NCT02005302

Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition

Study of Vitamin D2 Virus 1,25(OH)2-Vitamin D3 and Normal Protein Diet Virus Low Protein Diet in the Treatment of CKD-MBD and Malnutrition for Progressive CKD Patients

Last checked: Nov 19, 2026Latest source record: Dec 9, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

600

Planned (sponsor's estimate)

Start

Jan 2013

Primary completion

Dec 2015

Study completion Dec 2016

Sponsor

Lead sponsor
Wenhu LiuAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Beijing Municipal Science & Technology Commission
First posted
Dec 9, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multi-center, prospective, randomized, controlled study to verify the clinical effectiveness of K / DOQI guidelines. The efficiency and safety of Vitamin D2 and low protein diet treatment for prevention and treatment of CKD-MBD and malnutrition in CKD3-5 (ND) patients.

Conditions

  • Vitamin D Deficiency
  • Malnutrition

Interventions

  • 1,25(OH)2 Vitamin D3Drug

    Oral 1,25(OH)2 Vitamin D3 by 0.25 microgram once daily at start and regulate the dose according to the changes of blood levels of 25(OH)Vit D, calcium, phosphorus, and intact parathyroid hormone.

  • Vitamin D2Drug

    Oral Vit D2 1.25mg(50,000 unit) once weekly as a start and maintain 1.25mg(50,000 unit) once monthly according to the blood 25(OH)vitamin D level.

  • low protein dietDietary supplement

    Using nutritious software to make meals recipes and give dietary guidance for patients to reach the DPI goal of 0.6g-0.8g/kg/d.

  • normal protein dietDietary supplement

    Using nutritious software to make meals recipes and give dietary guidance for patients to reach the DPI goal of more than 0.8g/kg/d.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The changes on the blood levels of calcium, phosphorus, and intact parathyroid (iPTH) hormone during 36 monthsTime frame: 36 months
  2. The changes on the clinical indicators of nutritional statusTime frame: 36 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing XuanWu Hospital

    Beijing, Beijing Municipality, China

  • People's Liberation Army Air Force General Hospital

    Beijing, Beijing Municipality, China

  • People's Liberation Army General Hospital

    Beijing, Beijing Municipality, China

  • Sino-Japanese Friendship Hospital

    Beijing, Beijing Municipality, China

  • Beijing Friedship Hospital

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.